Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.
about
Cancer classification using the Immunoscore: a worldwide task forceMelanoma-restricted genesChanging paradigm through a genome-based approach to clinical and basic immunologyRNA amplification for successful gene profiling analysis.Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signaturesOptions available for profiling small samples: a review of sample amplification technology when combined with microarray profiling.Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation.The significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patientsControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentReflections upon human cancer immune responsiveness to T cell-based therapyAn immunologic portrait of cancerAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedHuman melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyA systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data.Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation.Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gammaMolecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapiesAnti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapyAssessment of fine needle aspiration feasibility and specimen adequacy for molecular diagnostics of benign vocal fold lesionsDevelopment and validation of predictive indices for a continuous outcome using gene expression profiles.MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment.Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcomaDual roles for immune metagenes in breast cancer prognosis and therapy prediction.Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment.CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancerMolecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsetsTherapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of conceptA gene expression signature associated with survival in metastatic melanomaT-cell intracellular antigens function as tumor suppressor genes.Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.A genetic inference on cancer immune responsivenessGlobal transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.The immunologic aspects of poxvirus oncolytic therapy
P2860
Q21245495-D147CC7A-EFA0-4D86-91EC-03A62777D998Q24793788-F7DC4603-AE1F-4A3E-9C5B-27B991EF4AD6Q24794751-DD610F15-33DD-4C0A-8CBC-723E8ED87A10Q24812532-6647077C-CB6C-4D09-A2AA-4D0503D9A092Q24812541-D9017C54-6D87-4BB3-839B-E048B37331F1Q25256748-B11CACC8-F959-4F8E-AFC3-3CF14E5861CFQ25257050-ADB81E8A-B279-4936-BFE6-AAF4C3443027Q26738665-C0B69069-BF6D-4857-A93E-F345A5DF7128Q26799117-1E84A711-F5EF-4D50-BF83-BF0D94B82790Q27004674-234E1A3C-5B82-4694-8B07-34378C5D3DFFQ27028000-8B58DECB-30F3-4AEE-91A4-5D340C35BE26Q28297381-DE20C614-654D-430C-9061-E4E59840687FQ30274920-E3C05E76-6F75-4608-B7C8-11B1A636AB69Q30423599-5155E72D-2EA0-4E40-B6CD-56A2FAC1CE56Q30438965-1C7EF84A-626D-465F-AB98-32D1AAF3009CQ30440347-7CE3D08C-F020-4B2C-8913-841F9C82603AQ30883005-A26407F6-8137-4049-85B1-BE1C07931B78Q33326902-9388E3C8-5536-4939-8AD7-309EAA6634A5Q33479314-99EA3D14-855E-476B-A213-08D3FE9FDB5FQ33693132-7833A29D-10B9-4D35-B5B9-F43A007D6017Q33705361-8E11682B-FCEE-47AE-AA9A-D823D778C9F2Q33738902-90C60DF9-8AD7-4923-8CC1-033C633BCAD2Q33753431-C8550CB0-1396-4100-B08B-DBAE5BF3769EQ33850118-CEB5DE5C-ABB5-4ED6-AB82-9BA73324CE28Q33889725-2A8850AD-BF90-4698-91FC-50AA9BDEB14BQ34044424-C3EEFB1F-832B-49BC-8448-9BD597924327Q34084824-553A469E-91C9-4CD3-8D95-9D9206633033Q34550822-D1F207AB-8637-4E8C-83EB-F3A78AC36C06Q34558758-37C9A547-1B7E-444E-B746-3DDEB94FD44AQ34606479-6F88D4D4-4DDF-4E66-A4CB-25B6762A94EFQ34682173-A659921A-E954-43B9-908C-6D765A68EA60Q34905454-372098BB-803B-4559-99E6-39BCBA93F3DDQ35012607-822CE6A0-8D26-43EF-A107-ABFBA1F1BB73Q35193892-21BF4FC2-ED2E-46A4-8406-140EAD1CDA2FQ35220047-E0D5446D-6925-490F-8E40-E6C277B927DEQ35274495-03A9B438-872E-4248-8BA7-18EC35C1C52DQ35541507-E89C310C-9587-4015-837B-50DB5820A638Q36057497-49A6B543-0CA6-4C7F-B21D-6FEF4BEC3019Q36076501-7382E701-0D23-44AD-8D9C-A0B2524570B0Q36115128-7053B474-96FA-4824-B9D0-DA8BAFAD0424
P2860
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Prospective molecular profilin ...... iers of immune responsiveness.
@ast
Prospective molecular profilin ...... iers of immune responsiveness.
@en
type
label
Prospective molecular profilin ...... iers of immune responsiveness.
@ast
Prospective molecular profilin ...... iers of immune responsiveness.
@en
prefLabel
Prospective molecular profilin ...... iers of immune responsiveness.
@ast
Prospective molecular profilin ...... iers of immune responsiveness.
@en
P2093
P2860
P1433
P1476
Prospective molecular profilin ...... fiers of immune responsiveness
@en
P2093
Ainhoa Perez-Diez
David Petersen
Edison T Liu
Esther Asaki
Francesco M Marincola
Galen A Ohnmacht
H Richard Alexander
John I Powell
Lance D Miller
P2860
P304
P407
P577
2002-07-01T00:00:00Z